But considering that it is difficult to sort out PD-1+CD8+ T cells in tumor tissue, based on two separate patient cohorts, a research confirmed that TCR repertoire diversity and clonality of peripheral PD-1+CD8+T cells may serve as noninvasive predictors of clinical outcomes after ICIs in patients with NSCLC [94]. The gene discussed is CD8A; the disease is neoplasm.